← All trials
NCT01541579
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2012
- Primary completion
- Jul 31, 2015
- Completion date
- Nov 30, 2016
- First posted
- Mar 1, 2012
- Last posted
- Nov 29, 2019
- Enrollment
- 278
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- TiGenixLead sponsor
- University of AmsterdamOverall official - principal investigator
- Free University of AmsterdamOverall official - principal investigator
- University of PadovaOverall official - principal investigator
- Maastricht UniversityOverall official - principal investigator
- University of Picardie Jules VerneOverall official - principal investigator
- University of Nice Sophia AntipolisOverall official - principal investigator
- Humboldt UniversityOverall official - principal investigator
- University of LilleOverall official - principal investigator
- University of BordeauxOverall official - principal investigator
- Aix-University of MarseilleOverall official - principal investigator
- University of BarcelonaOverall official - principal investigator
- University of BarcelonaStudy chair
- Hospital de ManisesOverall official - principal investigator
- University of ValenciaOverall official - principal investigator
- Autonomous University of MadridOverall official - principal investigator
- Hospital Universitario Ramon y CajalOverall official - principal investigator
- Universidad Autonoma de MadridOverall official - principal investigator
- Medical University of ViennaOverall official - principal investigator
- Katholieke Universiteit LeuvenOverall official - principal investigator
- University of Caen-NormandieOverall official - principal investigator
- University of Campania Luigi VanvitelliOverall official - principal investigator
- Virgen del Rocío University Hospital, SevilleOfficial
- Aix-University of MarseilleOfficial
- University of BarcelonaOfficial
- University of ValenciaOfficial
- University of Picardie Jules VerneOfficial
- Hospital de ManisesOfficial
- University of Caen-NormandieOfficial
- University of LilleOfficial
- Hospital Universitario Reina SofíaOfficial
- University of AmsterdamOfficial
- University of PadovaOfficial
- Hospital Universitario Ramon y CajalOfficial
- Medical University of ViennaOfficial
- University of Campania Luigi VanvitelliOfficial
- University of Nice Sophia AntipolisOfficial
- Humboldt UniversityOfficial
- Free University of AmsterdamOfficial
- Universidad Autonoma de MadridOfficial
- Universidad Autonoma de MadridOfficial
- Hospital de SaguntoOfficial
- Katholieke Universiteit LeuvenOfficial
- University of BordeauxOfficial
- Autonomous University of MadridOfficial
- Maastricht UniversityOfficial
- University of FlorenceOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.